FOXP3 and inflammatory bowel disease: One of the positively selected variant, rs12521868, has been previously identified as IBD-associated and encompasses foxp3 regulatory motif that interacts with RUNX1 which is involved in the control of T-cell mediated immune responses [65, 67].